avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.
Company profile
Ticker
AVDL, AVDL
Exchange
Website
CEO
Gregory Divis
Employees
Location
Fiscal year end
Industry (SIC)
Former names
FLAMEL TECHNOLOGIES SA
SEC CIK
Corporate docs
Subsidiaries
1) Avadel US Holdings, Inc. • B. Avadel Legacy Pharmaceuticals, LLC • C. Avadel Management Corporation • D. Avadel CNS Pharmaceuticals, LLC • 2) Flamel Ireland Ltd. • 3) Avadel Investment Company, Ltd. • 4) Avadel France Holding SAS • A. Avadel Research SAS • 5) Avadel Finance Ireland • A. Avadel Finance Cayman Ltd. ...
AVDL stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
15 Apr 24
8-A12B
Registration of securities on exchange
15 Apr 24
8-K
Other Events
4 Mar 24
8-K
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial
4 Mar 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights
8 Jan 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
9 Aug 23
Transcripts
AVDL
Earnings call transcript
2023 Q4
4 Mar 24
AVDL
Earnings call transcript
2023 Q3
8 Nov 23
AVDL
Earnings call transcript
2023 Q2
9 Aug 23
AVDL
Earnings call transcript
2022 Q4
30 Mar 23
AVDL
Earnings call transcript
2022 Q3
9 Nov 22
AVDL
Earnings call transcript
2022 Q2
9 Aug 22
AVDL
Earnings call transcript
2022 Q1
9 May 22
AVDL
Earnings call transcript
2021 Q4
17 Mar 22
AVDL
Earnings call transcript
2021 Q3
8 Nov 21
AVDL
Earnings call transcript
2021 Q2
9 Aug 21
Latest ownership filings
4
Richard J Kim
4 Mar 24
4
THOMAS S MCHUGH
4 Mar 24
4
Gregory J Divis
4 Mar 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G/A
JANUS HENDERSON GROUP PLC
13 Feb 24
SC 13G/A
GENDELL JEFFREY L
13 Feb 24
SC 13G
Polar Capital Holdings Plc
13 Feb 24
SC 13G/A
KOTLER KEVIN
12 Feb 24
4
THOMAS S MCHUGH
16 Jan 24
4
Mark Anthony McCamish
29 Dec 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 51.81 mm | 51.81 mm | 51.81 mm | 51.81 mm | 51.81 mm | 51.81 mm |
Cash burn (monthly) | (no burn) | 742.00 k | 12.06 mm | 13.27 mm | 12.74 mm | 9.65 mm |
Cash used (since last report) | n/a | 4.95 mm | 80.40 mm | 88.46 mm | 84.93 mm | 64.35 mm |
Cash remaining | n/a | 46.87 mm | -28.59 mm | -36.65 mm | -33.12 mm | -12.54 mm |
Runway (months of cash) | n/a | 63.2 | -2.4 | -2.8 | -2.6 | -1.3 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 100 |
Opened positions | 15 |
Closed positions | 16 |
Increased positions | 35 |
Reduced positions | 25 |
13F shares | Current |
---|---|
Total value | 555.78 bn |
Total shares | 56.58 mm |
Total puts | 292.30 k |
Total calls | 778.80 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
JHG Janus Henderson | 10.64 mm | $109.60 bn |
RTW Investments | 7.14 mm | $73.51 bn |
Gendell Jeffrey L | 5.62 mm | $57.84 bn |
Polar Capital | 4.51 mm | $46.48 bn |
Vivo Capital | 4.10 mm | $42.19 bn |
Wealth Effects | 2.41 mm | $24.82 bn |
Cowen And | 2.34 mm | $24.08 bn |
Vivo Opportunity | 2.25 mm | $0.00 |
Woodline Partners | 1.90 mm | $19.60 bn |
Adage Capital Partners GP, L.L.C. | 1.73 mm | $17.77 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Feb 24 | Kim Richard J | Stock Option ADSs | Grant | Acquire A | No | No | 13.57 | 147,000 | 1.99 mm | 147,000 |
20 Feb 24 | Thomas S Mchugh | Stock Option ADSs | Grant | Acquire A | No | No | 13.57 | 157,500 | 2.14 mm | 157,500 |
20 Feb 24 | Divis Gregory J | Stock Option ADSs | Grant | Acquire A | No | No | 13.57 | 600,000 | 8.14 mm | 600,000 |
16 Jan 24 | Thomas S Mchugh | ADSs | Buy | Acquire P | No | No | 14.5 | 2,000 | 29.00 k | 80,500 |
28 Dec 23 | McCamish Mark Anthony | ADSs | Sell | Dispose S | Yes | Yes | 14.53 | 75,000 | 1.09 mm | 67,025 |
News
Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target
9 Apr 24
10 Health Care Stocks With Whale Alerts In Today's Session
28 Mar 24
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
5 Mar 24
Craig-Hallum Maintains Buy on Avadel Pharmaceuticals, Raises Price Target to $22
5 Mar 24
Avadel Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results
5 Mar 24
Press releases
Avadel Pharmaceuticals Issues Statement On Patent Litigation
4 Mar 24
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4 Mar 24
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
26 Feb 24